DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV

Authors:
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]
  1. Yale Univ., New Haven, CT (United States)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH)
OSTI Identifier:
1547408
Alternate Identifier(s):
OSTI ID: 1636807
Grant/Contract Number:  
AC02-06CH11357; AI044616; GM049551; AI141172; AI112443; AI122384; EB000487; S10OD021527; P30 GM124165
Resource Type:
Accepted Manuscript
Journal Name:
Antiviral Research
Additional Journal Information:
Journal Volume: 167; Journal Issue: 07, 2019; Journal ID: ISSN 0166-3542
Publisher:
Elsevier
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; HIV-1; non-nucleoside reverse transcriptase inhibitor; long-acting nanoformulation; pharmacokinetic studies; mice model; x-ray crystallography

Citation Formats

Kudalkar, Shalley N., Ullah, Irfan, Bertoletti, Nicole, Mandl, Hanna K., Cisneros, José A., Beloor, Jagadish, Chan, Albert H., Quijano, Elias, Saltzman, W. Mark, Jorgensen, William L., Kumar, Priti, and Anderson, Karen S. Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV. United States: N. p., 2019. Web. doi:10.1016/j.antiviral.2019.04.010.
Kudalkar, Shalley N., Ullah, Irfan, Bertoletti, Nicole, Mandl, Hanna K., Cisneros, José A., Beloor, Jagadish, Chan, Albert H., Quijano, Elias, Saltzman, W. Mark, Jorgensen, William L., Kumar, Priti, & Anderson, Karen S. Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV. United States. https://doi.org/10.1016/j.antiviral.2019.04.010
Kudalkar, Shalley N., Ullah, Irfan, Bertoletti, Nicole, Mandl, Hanna K., Cisneros, José A., Beloor, Jagadish, Chan, Albert H., Quijano, Elias, Saltzman, W. Mark, Jorgensen, William L., Kumar, Priti, and Anderson, Karen S. Fri . "Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV". United States. https://doi.org/10.1016/j.antiviral.2019.04.010. https://www.osti.gov/servlets/purl/1547408.
@article{osti_1547408,
title = {Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV},
author = {Kudalkar, Shalley N. and Ullah, Irfan and Bertoletti, Nicole and Mandl, Hanna K. and Cisneros, José A. and Beloor, Jagadish and Chan, Albert H. and Quijano, Elias and Saltzman, W. Mark and Jorgensen, William L. and Kumar, Priti and Anderson, Karen S.},
abstractNote = {},
doi = {10.1016/j.antiviral.2019.04.010},
journal = {Antiviral Research},
number = 07, 2019,
volume = 167,
place = {United States},
year = {Fri Apr 26 00:00:00 EDT 2019},
month = {Fri Apr 26 00:00:00 EDT 2019}
}

Journal Article:

Citation Metrics:
Cited by: 12 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility
journal, September 2013

  • Bollini, Mariela; Cisneros, José A.; Spasov, Krasimir A.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18
  • DOI: 10.1016/j.bmcl.2013.06.091

Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point
journal, July 2014

  • Bose, Tanima; Latawiec, Diane; Mondal, Partha Pratim
  • Journal of Nanoparticle Research, Vol. 16, Issue 8
  • DOI: 10.1007/s11051-014-2527-7

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
journal, November 2012

  • Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques
  • Nature Reviews Drug Discovery, Vol. 11, Issue 12
  • DOI: 10.1038/nrd3845

The CCP4 suite programs for protein crystallography
journal, September 1994


High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
journal, January 2008

  • Das, K.; Bauman, J. D.; Clark, A. D.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 5
  • DOI: 10.1073/pnas.0711209105

Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen
journal, January 2001

  • Delaugerre, C.; Rohban, R.; Simon, A.
  • Journal of Medical Virology, Vol. 65, Issue 3
  • DOI: 10.1002/jmv.2055

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design
journal, November 2012

  • Frey, Kathleen M.; Bollini, Mariela; Mislak, Andrea C.
  • Journal of the American Chemical Society, Vol. 134, Issue 48
  • DOI: 10.1021/ja3092642

Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase
journal, March 2014

  • Frey, Kathleen M.; Gray, William T.; Spasov, Krasimir A.
  • Chemical Biology & Drug Design, Vol. 83, Issue 5
  • DOI: 10.1111/cbdd.12266

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily: Human CYP2C subfamily
journal, October 2001


Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance
journal, September 2015


Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell–Cell HIV Transmission
journal, November 2015


Efficient Drug Lead Discovery and Optimization
journal, June 2009

  • Jorgensen, William L.
  • Accounts of Chemical Research, Vol. 42, Issue 6
  • DOI: 10.1021/ar800236t

Prediction of drug solubility from structure
journal, March 2002


XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors
journal, June 2002


Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
journal, June 1992


Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
journal, February 2017

  • Kudalkar, Shalley N.; Beloor, Jagadish; Chan, Albert H.
  • Molecular Pharmacology, Vol. 91, Issue 4
  • DOI: 10.1124/mol.116.107755

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection
journal, December 2017

  • Kudalkar, Shalley N.; Beloor, Jagadish; Quijano, Elias
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 4
  • DOI: 10.1073/pnas.1717932115

PROCHECK: a program to check the stereochemical quality of protein structures
journal, April 1993

  • Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.
  • Journal of Applied Crystallography, Vol. 26, Issue 2
  • DOI: 10.1107/S0021889892009944

Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents
journal, September 2016


Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
journal, September 2014

  • Lee, Won-Gil; Frey, Kathleen M.; Gallardo-Macias, Ricardo
  • ACS Medicinal Chemistry Letters, Vol. 5, Issue 11
  • DOI: 10.1021/ml5003713

Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase
journal, November 2015

  • Lee, Won-Gil; Frey, Kathleen M.; Gallardo-Macias, Ricardo
  • Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 21
  • DOI: 10.1016/j.bmcl.2015.06.074

Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group
journal, October 2013

  • Lee, Won-Gil; Gallardo-Macias, Ricardo; Frey, Kathleen M.
  • Journal of the American Chemical Society, Vol. 135, Issue 44
  • DOI: 10.1021/ja408917n

Solvent content of protein crystals
journal, April 1968


Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Collaboration gets the most out of software
journal, September 2013


Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
journal, May 2008

  • Riddler, Sharon A.; Haubrich, Richard; DiRienzo, A. Gregory
  • New England Journal of Medicine, Vol. 358, Issue 20
  • DOI: 10.1056/NEJMoa074609

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors
journal, April 2012

  • Sun, Lian-Qi; Qin, Bingjie; Huang, Li
  • Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 7
  • DOI: 10.1016/j.bmcl.2012.02.055

Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells
journal, December 2007